P1015 Subcutaneous infliximab effectively manages clinical outcomes of Inflammatory Bowel Disease independently of various confounding factors
- DOI
- 10.1093/ecco-jcc/jjad212.1145
- Published
- 2024-01-01
- Container
- Journal of Crohn's and Colitis
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ecco-jcc/jjad212.1145,
title = {P1015 Subcutaneous infliximab effectively manages clinical outcomes of Inflammatory Bowel Disease independently of various confounding factors},
author = {A. Buisson and F. Cummings and S. Subramanian and S. Rahmany and M. Fumery and B. Kwon and S. Park and Y. Lee and P. Smith},
year = {2024},
journal = {Journal of Crohn's and Colitis},
doi = {10.1093/ecco-jcc/jjad212.1145},
url = {https://doi.org/10.1093/ecco-jcc/jjad212.1145}
}RIS
TY - JOUR TI - P1015 Subcutaneous infliximab effectively manages clinical outcomes of Inflammatory Bowel Disease independently of various confounding factors AU - A. Buisson AU - F. Cummings AU - S. Subramanian AU - S. Rahmany AU - M. Fumery AU - B. Kwon AU - S. Park AU - Y. Lee AU - P. Smith PY - 2024 JO - Journal of Crohn's and Colitis DO - 10.1093/ecco-jcc/jjad212.1145 UR - https://doi.org/10.1093/ecco-jcc/jjad212.1145 ER -
APA
Buisson, A., Cummings, F., Subramanian, S., Rahmany, S., Fumery, M., Kwon, B., Park, S., Lee, Y., & Smith, P. (2024). P1015 Subcutaneous infliximab effectively manages clinical outcomes of Inflammatory Bowel Disease independently of various confounding factors. Journal of Crohn's and Colitis. https://doi.org/10.1093/ecco-jcc/jjad212.1145
Source records
- hal · retrieved 2026-09-27T13:20:24.669Z